Company

Cannara Biotech, Inc.

Headquarters: Montreal, QC, Canada

CEO: Mr. Zohar Krivorot

TSXV: LOVE +5.00%

Market Cap

C$60.3 Million

CAD as of July 1, 2024

US$43.9 Million

Market Cap History

Cannara Biotech, Inc. Categories

Canada Healthcare Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

Cannara Biotech, Inc. market capitalization over time

Evolution of Cannara Biotech, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Cannara Biotech, Inc.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector:
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Detailed Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Montreal, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Cannara Biotech, Inc. has the following listings and related stock indices.


Stock: TSXV: LOVE wb_incandescent

Stock: FSX: 8CB wb_incandescent

Stock: OTC: LOVFF wb_incandescent

Details

Headquarters:

333 Decarie boulevard

Suite 200 St-Laurent

Montreal, QC H4N 3M9

Canada